HSBC plans $1 billion sale of Singapore life insurance manufacturing operations

Desk report: HSBC has launched the sale of its Singapore life insurance manufacturing business, targeting a valuation of more than US$1 billion, according to sources familiar with the matter. The bank has appointed JPMorgan as financial adviser and has begun approaching potential buyers, including Japanese insurers Nippon Life and Dai-ichi Life. Non-binding bids are expected within about a month.

The transaction covers only HSBC’s life insurance manufacturing operations in Singapore. This unit designs and underwrites life insurance products. HSBC will retain its insurance distribution capabilities and continue offering products to clients through its banking and wealth management channels.

The move highlights HSBC’s broader strategy to streamline operations and sharpen its focus on core growth areas. Under CEO Georges Elhedery, the bank has accelerated efforts to simplify its global footprint and improve returns. Last year, HSBC completed 11 divestments worldwide as part of this plan.

Although insurance remains one of HSBC’s fastest-growing fee-based businesses, the Singapore manufacturing unit has struggled to secure a top-five position in the local market. This performance gap prompted a strategic review earlier in 2026.

The potential sale also reflects wider industry trends. Japanese insurers are actively pursuing overseas acquisitions as growth slows in their domestic market. Southeast Asia offers strong long-term prospects, supported by rising affluence, an expanding middle-class population and increasing demand for protection and savings products.

A successful deal would represent a significant portfolio shift for HSBC in one of its key Asian hubs. It would also signal the bank’s commitment to optimising capital allocation while maintaining a strong presence in insurance distribution. For buyers, the asset offers a platform in a stable and competitive market with solid growth fundamentals.